Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Winstanley

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Infectious Diseases|May 2, 2009
In vivo and in vitro efficacy of amodiaquine against Plasmodium falciparum in an area of continued use of 4-aminoquinolines in East AfricaPhilip Sasi, Abdi Abdulrahaman, Leah Mwai, et al.
Pharmacogenomics|September 19, 2009
Effects of genetic variation at the CYP2C19/CYP2C9 locus on pharmacokinetics of chlorcycloguanil in adult GambiansRamatoulie E Janha, Fatoumatta Sisay-Joof, Majidah Hamid-Adiamoh, et al.
Lancet (London, England)|September 22, 2009
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trialsJohn J Aponte, David Schellenberg, Andrea Egan, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Infectious Diseases|May 2, 2009
In vivo and in vitro efficacy of amodiaquine against Plasmodium falciparum in an area of continued use of 4-aminoquinolines in East AfricaPhilip Sasi, Abdi Abdulrahaman, Leah Mwai, et al.
Pharmacogenomics|September 19, 2009
Effects of genetic variation at the CYP2C19/CYP2C9 locus on pharmacokinetics of chlorcycloguanil in adult GambiansRamatoulie E Janha, Fatoumatta Sisay-Joof, Majidah Hamid-Adiamoh, et al.
Lancet (London, England)|September 22, 2009
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trialsJohn J Aponte, David Schellenberg, Andrea Egan, et al.
Pageof 2